• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Everolimus for the Treatment of Tuberous Sclerosis Complex-Related Cardiac Rhabdomyomas in Pediatric Patients.

作者信息

Dahdah Nagib

机构信息

Division of Pediatric Cardiology, CHU Sainte-Justine, University of Montreal, Quebec, Canada.

出版信息

J Pediatr. 2017 Nov;190:21-26.e7. doi: 10.1016/j.jpeds.2017.06.076. Epub 2017 Sep 6.

DOI:10.1016/j.jpeds.2017.06.076
PMID:28888564
Abstract
摘要

相似文献

1
Everolimus for the Treatment of Tuberous Sclerosis Complex-Related Cardiac Rhabdomyomas in Pediatric Patients.依维莫司治疗小儿结节性硬化症相关心脏横纹肌瘤
J Pediatr. 2017 Nov;190:21-26.e7. doi: 10.1016/j.jpeds.2017.06.076. Epub 2017 Sep 6.
2
Cardiac Rhabdomyomas in Tuberous Sclerosis Complex.结节性硬化症中的心脏横纹肌瘤
J Pediatr. 2018 Jan;192:264-264.e1. doi: 10.1016/j.jpeds.2017.09.050. Epub 2017 Nov 8.
3
Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.接受依维莫司治疗的新生儿中，与结节性硬化症相关的有症状多发性心脏横纹肌瘤的消退。
J Trop Pediatr. 2015 Feb;61(1):74-7. doi: 10.1093/tropej/fmu056. Epub 2014 Oct 24.
4
Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia.依维莫司治疗一名患有横纹肌瘤并导致严重心律失常的新生儿。
Cardiol Young. 2015 Oct;25(7):1411-4. doi: 10.1017/S1047951114002261.
5
Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas.依维莫司治疗结节性硬化症相关心脏横纹肌瘤所致严重心律失常。
Am J Med Genet A. 2021 May;185(5):1525-1531. doi: 10.1002/ajmg.a.62120. Epub 2021 Feb 16.
6
Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex.依维莫司使一名患有结节性硬化症复合体的新生儿的巨大心脏横纹肌瘤和大型肾血管平滑肌脂肪瘤几乎消退。
Cardiol Young. 2016 Jun;26(5):1025-8. doi: 10.1017/S1047951116000421. Epub 2016 Apr 8.
7
Rapid Involution of Large Cardiac Rhabdomyomas With Everolimus Therapy.依维莫司治疗使心脏大横纹肌瘤快速消退
World J Pediatr Congenit Heart Surg. 2021 May;12(3):426-429. doi: 10.1177/2150135118822711. Epub 2019 May 9.
8
Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial.依维莫司治疗结节性硬化症相关心脏横纹肌瘤：ORACLE 研究方案（依维莫司治疗结节性硬化症相关心脏横纹肌瘤的随机、多中心、安慰剂对照、双盲二期试验）。
Cardiol Young. 2020 Mar;30(3):337-345. doi: 10.1017/S1047951119003147. Epub 2020 Jan 27.
9
Use of everolimus for cardiac rhabdomyomas in a very-low-birthweight infant.依维莫司在极低出生体重儿心脏横纹肌瘤治疗中的应用。
Pediatr Int. 2021 Jun;63(6):726-727. doi: 10.1111/ped.14472. Epub 2021 May 26.
10
Regression of a cardiac rhabdomyoma in a patient receiving everolimus.患者接受依维莫司治疗后心脏横纹肌瘤消退。
Pediatrics. 2011 May;127(5):e1335-7. doi: 10.1542/peds.2010-2910. Epub 2011 Apr 4.

引用本文的文献

1
Everolimus and sirolimus in the treatment of cardiac rhabdomyomas in neonates.依维莫司和西罗莫司用于治疗新生儿心脏横纹肌瘤。
Pediatr Res. 2025 Apr 26. doi: 10.1038/s41390-025-04043-8.
2
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results.西罗莫司对结节性硬化症的预防性治疗：I期安全性和疗效结果。
Ann Child Neurol Soc. 2024 Jun;2(2):106-119. doi: 10.1002/cns3.20070. Epub 2024 Apr 22.
3
Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus.
病例报告：低剂量依维莫司治疗新生儿巨大心脏横纹肌瘤的加速消退
Front Pediatr. 2023 Feb 15;11:1109646. doi: 10.3389/fped.2023.1109646. eCollection 2023.
4
Common benign primary pediatric cardiac tumors: a primer for radiologists.常见的小儿原发性心脏良性肿瘤：放射科医生入门指南
Jpn J Radiol. 2023 May;41(5):477-487. doi: 10.1007/s11604-022-01371-1. Epub 2022 Dec 10.
5
Monitoring and Managing Patients with Tuberous Sclerosis Complex: Current State of Knowledge.结节性硬化症患者的监测与管理：当前知识现状
J Multidiscip Healthc. 2022 Jul 14;15:1469-1480. doi: 10.2147/JMDH.S266990. eCollection 2022.
6
Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications.使用依维莫司治疗新生儿心脏横纹肌瘤和持续性心律失常：益处与并发症
Ann Pediatr Cardiol. 2022 Jan-Feb;15(1):58-60. doi: 10.4103/apc.apc_11_21. Epub 2022 Jun 14.
7
Perfect match: mTOR inhibitors and tuberous sclerosis complex.完美匹配：mTOR 抑制剂与结节性硬化症。
Orphanet J Rare Dis. 2022 Mar 4;17(1):106. doi: 10.1186/s13023-022-02266-0.
8
Society for Cardiovascular Magnetic Resonance 2020 Case of the Week series.社会心血管磁共振 2020 案例周报系列。
J Cardiovasc Magn Reson. 2021 Oct 11;23(1):108. doi: 10.1186/s12968-021-00799-0.
9
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' Perspectives.依维莫司治疗结节性硬化症患者的疗效、保留率和耐受性：基于患者观点的调查研究。
CNS Drugs. 2021 Oct;35(10):1107-1122. doi: 10.1007/s40263-021-00839-4. Epub 2021 Jul 17.
10
Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review.依维莫司低剂量治疗新生儿结节性硬化症心脏横纹肌瘤的疗效：病例报告及文献综述
Pediatr Rep. 2021 Mar 1;13(1):104-112. doi: 10.3390/pediatric13010015.